Navigation Links
Antigen Discovery Inc. Awarded a SBIR Phase II Grant to Commercialize Novel Antigens for Serodiagnostic Products and Vaccine Development
Date:7/3/2008

he same infection."

About Antigen Discovery Inc.

Antigen Discovery Inc. (formerly ImmPORT Therapeutics Inc.) is a privately held biotech company with innovative technologies that offer unprecedented advantages for the rapid development of safer and more effective vaccines and diagnostic products. The Company's high throughput proteome microarray chip fabrication and screening platform provides an order of magnitude of improvement over current antigen/biomarker discovery technologies. The technology also has potential applications in the identification of markers for autoimmune disease and cancer.


'/>"/>
SOURCE Antigen Discovery Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. U.S. Government Accepts $192 Million of sanofi pasteur H5N1 Bulk Vaccine Antigen for Pandemic Stockpile
2. Dendreon Publishes Manuscript on CD54 as a Surrogate Marker of Antigen Presenting Cell Activation
3. Joseph B. Bolen, Ph.D. from Millennium to Conference Chair Cancer Sessions at IBCs Drug Discovery & Development of Innovative Therapeutics Conference
4. Exelixis and GlaxoSmithKline Agree to Successfully Conclude Six-Year Discovery and Development Collaboration
5. Discovery by UC Riverside physicists could enable development of faster computers
6. Cellectricon and AstraZeneca - Partners in New High Throughput Ion Channel Drug Discovery Technology
7. Oncomine(TM) Again Key to Prostate Cancer Discovery
8. Nuevolution Announces Drug Discovery Alliance With Lexicon Pharmaceuticals
9. Pharmacopeia Advances Strategic Plan to Focus Resources on Development and Later-Stage Discovery Programs
10. WuXi PharmaTech (NYSE: WX) Appoints Dr. Peng Wang as VP of Discovery Biology
11. Genetic Engineering and Biotechnology News (GEN) Reports on Mass Spec in Drug Discovery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/27/2015)... 27, 2015 According to the new ... Media, Pre-formulated Media), by Application (Biobanking, Regenerative Medicine, Drug Discovery), ... Europe , Asia-Pacific , Rest of ... biopreservation media market was valued at $247.7 million in 2014, ... 2019, at a CAGR of 18.2% between 2014 and 2019. ...
(Date:7/27/2015)... -- IDEXX Laboratories, Inc. (NASDAQ: IDXX ) announced ... 100,000 specimens to IDEXX Reference Laboratories for symmetric dimethylarginine, ... since the breakthrough kidney function test launched in the ... of suffering and death in cats and dogs. The ... accepted kidney disease prevalence data showing that 1 in ...
(Date:7/25/2015)... ... July 25, 2015 , ... Technology leader Anton ... checks and adjusts the surface temperature of the measuring prism. This is required ... data traceability and documentation are key requirements. It is likely that no refractometer ...
(Date:7/24/2015)... Equity Research Institute has initiated ... PDLI ), Arena Pharmaceuticals Inc. (NASDAQ: ARNA ... Inc. (NASDAQ: NWBO ), and Acorda Therapeutics Inc. ... BioPharma can be accessed at https://www.EquityResearchInstitute.com/reports?keyword=PDLI On ... 5,146.41, down 0.49%, the Dow Jones Industrial Average declined ...
Breaking Biology Technology:Global Biopreservation Media Market to be Worth $571.5 Million by 2019 2Global Biopreservation Media Market to be Worth $571.5 Million by 2019 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 2Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 3Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 4Over 100,000 Pets Tested with New IDEXX SDMA Kidney Function Test Since Product Launch on July 13 5It’s T-Time for Refractometers: On-site Temperature Check Now Available 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 2Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 3Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 4Biotechnology Stocks in Motion -- PDL BioPharma, Arena Pharma, StemCells, Northwest Biotherapeutics, and Acorda Therapeutics 5
... Incremental Data to be Presented at ASCO GI ... to Oxaliplatin in First-Line Colorectal Cancer Treatment -SOUTH ... Inc. (Nasdaq: PARD ), a biopharmaceutical ... updated efficacy and safety data from its randomized, ...
... a top question of Jatropha developers is, "What impact ... sector and its prominence as a viable, sustainable biofuel?" ... 20 January webinar has been scheduled. As a precursor ... lend crucial answers to hard-hitting inquiries by Jatropha investors. ...
... will be presented at Photonics West 2009PITTSFIELD, Mass., ... international society for optics and photonics, and Laurin ... 67 finalist companies for the 2008 Prism Awards ... photonics industry worldwide. The Prism Awards, introduced for ...
Cached Biology Technology:Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 2Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 3Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 4Poniard Pharmaceuticals Announces Positive Tumor Response and Neuropathy Data from Phase 2 Clinical Trial of Picoplatin in Metastatic Colorectal Cancer 5Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights 2Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights 3Jatropha Sector Reality Check: Still Viable In Volatile Times? Upcoming Webcast Shares Latest Insights 4SPIE and Laurin Publishing Announce Prism Awards Finalists 2SPIE and Laurin Publishing Announce Prism Awards Finalists 3
(Date:7/9/2015)... 07, 2015 Research ... of the "Biometrics for Banking; Market & ... report to their offering. The adoption ... this growth and the forecast is that by ... for companies involved in delivering biometric systems to ...
(Date:7/8/2015)... , July 8, 2015  Trovagene, Inc. (NASDAQ: ... diagnostics, today announced the launch of a study ... Precision Cancer Monitoring℠ (PCM) technology for predicting response ... or a combination of the novel immunotherapy agents ... a PD-1 inhibitor. The 50-patient study will be ...
(Date:7/2/2015)... , June 25, 2015 ... announced the addition of the "Natural Language ... Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) ... their offering. The key vendors occupying ... HP, IBM Corporation, Microsoft Corporation, NetBase Solutions, SAS ...
Breaking Biology News(10 mins):Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 2Global Banking Biometrics Market 2015-2020 - Market & Technology Analysis, Adoption Strategies and Forecasts 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 2Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 3Trovagene Initiates Study to Monitor Response to Immunotherapy in Melanoma Patients Using its Precision Cancer Monitoring Platform 4Natural Language Processing Market by Type (Rule-Based, Statistical, and Hybrid), Technologies (Recognition, IVR, OCR, Pattern & Image Recognition) - Worldwide Forecast to 2020 2
... A compound derived from cottonseed could help improve the ... researchers at the University of Michigan Comprehensive Cancer Center ... July issue of the journal Molecular Cancer Therapeutics, could ... to surgically removing the cancer, helping patients preserve vital ...
... water droplets to create adhesive bonds almost as strong as ... , The new beetle-inspired switch, designed by Cornell University engineers, ... -- a millionth of a meter. The switches can be ... Like the transistor, whose varied uses became apparent only following ...
... the National Institute of Allergy and Infectious Diseases (NIAID), ... the surprising discovery that flaviviruses, which cause such serious ... of encephalitis, evade immune system defenses in different ways ... ticks. This finding could lead to new approaches to ...
Cached Biology News:Compound from Chinese medicine shows promise in head and neck cancer 2Compound from Chinese medicine shows promise in head and neck cancer 3Beetle-inspired switch uses water for bonding 2Scientists show that tick-borne flaviviruses use a novel mechanism to evade host defenses 2Scientists show that tick-borne flaviviruses use a novel mechanism to evade host defenses 3
RABBIT ANTI HUMAN APP (KP1 DOMAIN) Immunogen: Synthetic peptide composed of amino acids 292-312 from the KPI domain of human APP....
Anti-Goat HRP-AEC Cell & Tissue Staining Kit...
... The CultureWell cell culture ... for preparing cultured cells for ... uses medical-grade silicone gaskets preassembled ... cell culture plates. The entire ...
... Zero Background/Kan Cloning Kit includes ... resistance for selection in E. ... positive selection to eliminate high ... of the reagents you need ...
Biology Products: